GlassScriptPhysician profile
Thomas M Darden
NPI 1992779946
$1,844.27
in general payments reported to CMS, 2019-2025
25 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $109 · 2021: $202 · 2022: $573 · 2023: $207 · 2024: $284 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $246.69 | 2019-2023 | Cmf |
| Boston Scientific Corporation | $229.67 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $184.99 | 2020-2022 | |
| Organogenesis INC. | $161.21 | 2020-2023 | Puraply |
| Treace Medical Concepts, INC. | $149.56 | 2024 | |
| Bioventus LLC | $126.40 | 2022-2025 | Exogen Ultrasound Bone Healing System, Durolane, Xcell |
| Pacira Pharmaceuticals Incorporated | $103.91 | 2021-2025 | Exparel, Zilretta |
| Curonix LLC | $97.50 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Depuy Synthes Sales INC. | $94.02 | 2019-2022 | |
| Pacira Therapeutics, INC. | $78.01 | 2019 | |
| Smith+Nephew, INC. | $66.39 | 2022 | |
| Horizon Therapeutics Plc | $60.82 | 2019-2022 | |
| Baxter Healthcare | $26.10 | 2022 | |
| Avanos Medical | $22.52 | 2022 | |
| Moximed, INC | $22.30 | 2024 | Misha Knee System, Small, Left |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $20.04 | 2019 | |
| Innovation Technologies INC | $19.69 | 2024 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $19.49 | 2024 | |
| Medline Industries LP | $18.41 | 2024 | |
| Si-Bone, INC. | $18.32 | 2019 | |
| Endo Pharmaceuticals INC. | $17.89 | 2022 | |
| Spine Wave, INC. | $16.27 | 2019 | |
| Orthogenrx INC. | $14.96 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.67 | 2019 | |
| Baudax Bio INC. | $14.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Darden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.